Ramon Eritja
Barcelona, CT 08034, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
G-quadruplexes as therapeutic platforms for anticancer drug delivery: from intrinsic cytotoxicity to drug delivery and nanotechnology.
Journal: Expert opinion on drug delivery
Published: April 14, 2026
Covalent functionalization of polymeric nanoparticles prepared from nano-emulsion templates for gene silencing and antioxidant delivery at neuronal level.
Journal: International journal of pharmaceutics
Published: December 23, 2025
Engineering G-quadruplex aptamer-5-fluoro-2'-deoxyuridine conjugates: Impact of tail orientation and RNA spacer insertion on structure and antitumor activity.
Journal: International journal of biological macromolecules
Published: November 17, 2025
Enhanced i-Motif Stability through Consecutive 2',2'-Difluorocytidine Incorporation.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: September 30, 2025
The Effect of 2'F-RNA on I-Motif Structure and Stability.
Journal: Molecules (Basel, Switzerland)
Published: July 12, 2025
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
Journal: American journal of human genetics
Published: July 04, 2025
Resolution of complex mixtures of duplex and antiparallel triplex DNA structures by capillary electrophoresis and multivariate analysis.
Journal: Talanta
Published: December 19, 2024
On the interaction of anticancer G-quadruplex ligands with GalNAc-functionalized G-quadruplex-forming carriers for selective recognition and treatment of hepatocellular carcinoma.
Journal: Bioorganic chemistry
Published: October 04, 2024
Assessment of methodologies based on the formation of antiparallel triplex DNA structures and fluorescent silver nanoclusters for the detection of pyrimidine-rich sequences.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: September 10, 2024
Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1.
Journal: Cells
Published: August 31, 2024
Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 30, 2024
Last Updated: 09/26/2026